Chison Medical Technologies Co., Ltd. (SHA:688358)
China
· Delayed Price · Currency is CNY 32.52
+0.70 (2.20%)
Mar 10, 2026, 10:15 AM CST
SHA:688358 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 447.35 | 468.13 | 480.89 | 375.69 | 394.91 | Upgrade
|
| Other Revenue | - | 0.57 | 2.95 | 5.16 | 2.9 | Upgrade
|
| Revenue | 447.35 | 468.7 | 483.84 | 380.84 | 397.81 | Upgrade
|
| Revenue Growth (YoY) | -4.55% | -3.13% | 27.05% | -4.26% | 19.43% | Upgrade
|
| Cost of Revenue | - | 196.94 | 208.34 | 160.6 | 178.89 | Upgrade
|
| Gross Profit | 447.35 | 271.75 | 275.5 | 220.24 | 218.92 | Upgrade
|
| Selling, General & Admin | - | 92.63 | 84.26 | 81.84 | 76.15 | Upgrade
|
| Research & Development | - | 79.63 | 77.07 | 77.88 | 72.29 | Upgrade
|
| Other Operating Expenses | 319.86 | -2.68 | -3.43 | -4.3 | -2.49 | Upgrade
|
| Operating Expenses | 319.86 | 171.29 | 161.48 | 154.02 | 146.68 | Upgrade
|
| Operating Income | 127.49 | 100.47 | 114.02 | 66.22 | 72.24 | Upgrade
|
| Interest Expense | - | -0.38 | -0.36 | -0.11 | -0.07 | Upgrade
|
| Interest & Investment Income | - | 37.32 | 29.6 | 16.43 | 19.59 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 10.48 | 5.49 | 26.13 | -6.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.7 | -0.63 | -0.38 | -0.38 | -0.37 | Upgrade
|
| EBT Excluding Unusual Items | 129.19 | 147.26 | 148.36 | 108.29 | 85.37 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.17 | 2.93 | -1.37 | 0.43 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 4.61 | 2.96 | -0.5 | 30.26 | Upgrade
|
| Asset Writedown | - | - | - | -0.51 | -1.59 | Upgrade
|
| Other Unusual Items | - | 4.8 | 7.94 | 9.22 | 10.08 | Upgrade
|
| Pretax Income | 129.19 | 156.85 | 162.19 | 115.13 | 124.54 | Upgrade
|
| Income Tax Expense | 12.56 | 16.34 | 15.71 | 9.29 | 12.07 | Upgrade
|
| Net Income | 116.63 | 140.51 | 146.48 | 105.84 | 112.47 | Upgrade
|
| Net Income to Common | 116.63 | 140.51 | 146.48 | 105.84 | 112.47 | Upgrade
|
| Net Income Growth | -16.99% | -4.08% | 38.40% | -5.89% | 12.88% | Upgrade
|
| Shares Outstanding (Basic) | 112 | 112 | 110 | 113 | 112 | Upgrade
|
| Shares Outstanding (Diluted) | 112 | 112 | 110 | 113 | 112 | Upgrade
|
| Shares Change (YoY) | 0.57% | 1.25% | -2.19% | 0.11% | 0.79% | Upgrade
|
| EPS (Basic) | 1.04 | 1.26 | 1.33 | 0.94 | 1.00 | Upgrade
|
| EPS (Diluted) | 1.04 | 1.26 | 1.33 | 0.94 | 1.00 | Upgrade
|
| EPS Growth | -17.46% | -5.26% | 41.49% | -6.00% | 12.00% | Upgrade
|
| Free Cash Flow | - | 131.83 | 51.9 | 11.53 | 0.78 | Upgrade
|
| Free Cash Flow Per Share | - | 1.18 | 0.47 | 0.10 | 0.01 | Upgrade
|
| Dividend Per Share | - | 1.000 | 0.800 | 0.700 | 0.357 | Upgrade
|
| Dividend Growth | - | 25.00% | 14.29% | 96.02% | -37.50% | Upgrade
|
| Gross Margin | 100.00% | 57.98% | 56.94% | 57.83% | 55.03% | Upgrade
|
| Operating Margin | 28.50% | 21.44% | 23.57% | 17.39% | 18.16% | Upgrade
|
| Profit Margin | 26.07% | 29.98% | 30.28% | 27.79% | 28.27% | Upgrade
|
| Free Cash Flow Margin | - | 28.13% | 10.73% | 3.03% | 0.19% | Upgrade
|
| EBITDA | 138.75 | 111.73 | 125.68 | 78.3 | 81.53 | Upgrade
|
| EBITDA Margin | 31.02% | 23.84% | 25.97% | 20.56% | 20.50% | Upgrade
|
| D&A For EBITDA | 11.26 | 11.26 | 11.66 | 12.07 | 9.29 | Upgrade
|
| EBIT | 127.49 | 100.47 | 114.02 | 66.22 | 72.24 | Upgrade
|
| EBIT Margin | 28.50% | 21.44% | 23.57% | 17.39% | 18.16% | Upgrade
|
| Effective Tax Rate | 9.72% | 10.42% | 9.69% | 8.07% | 9.69% | Upgrade
|
| Revenue as Reported | - | 468.7 | 483.84 | 380.84 | 397.81 | Upgrade
|
| Advertising Expenses | - | 5.27 | 3.38 | 2.64 | 4.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.